Reply

Affiliations

Comment

Jeffrey R Curtis et al. Arthritis Rheumatol. 2021 Sep.

. 2021 Sep;73(9):1771-1772.

doi: 10.1002/art.41718. Epub 2021 Aug 9.

No abstract available

Comment on

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission.
Curtis JR, Emery P, Karis E, Haraoui B, Bykerk V, Yen PK, Kricorian G, Chung JB. Curtis JR, et al. Arthritis Rheumatol. 2021 May;73(5):759-768. doi: 10.1002/art.41589. Epub 2021 Mar 24. Arthritis Rheumatol. 2021. PMID: 33205906 Free PMC article. Clinical Trial.
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients Receiving Combination Therapy: Comment on the Article by Curtis et al.
Roongta R, Mondal S, Ghosh A. Roongta R, et al. Arthritis Rheumatol. 2021 Sep;73(9):1771. doi: 10.1002/art.41719. Epub 2021 Aug 9. Arthritis Rheumatol. 2021. PMID: 33750021 No abstract available.

1. Studenic P, Smolen JS, Aletaha D. Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitions. Ann Rheum Dis 2012;71:1702-5.
1. Aletaha D, Wang X, Zhong S, Florentinus S, Monastiriakos K, Smolen JS. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission. Semin Arthritis Rheum 2020;50:276-84.
1. Van Vollenhoven RF, Østergaard M, Leirisalo-Repo M, Uhlig T, Jansson M, Larsson E, et al. Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis. Ann Rheum Dis 2016;75:52-8.
1. Emery P, Breedveld F, van der Heijde D, Ferraccioli G, Dougados M, Robertson D, et al. Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study. Arthritis Rheum 2010;62:674-82.